Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Naunyn Schmiedebergs Arch Pharmacol
2010 Mar 01;3813:271-83. doi: 10.1007/s00210-009-0456-2.
Show Gene links
Show Anatomy links
Synthesis and characterisation of NS13558: a new important tool for addressing KCa1.1 channel function ex vivo.
Bentzen BH
,
Andersen RW
,
Olesen SP
,
Grunnet M
,
Nardi A
.
???displayArticle.abstract???
Pharmacological activation of the large-conductance Ca(2+)-activated K(+) channel (KCa1.1) in the cardiac inner mitochondrial membrane has been found to protect the heart against ischemia reperfusion injuries. However, there are concerns about the selectivity of the pharmacological tools used to modulate the channel. Here, we address this issue by synthesising a methylated analogue of the tool KCa1.1 channel activator NS11021. The compound (NS13558) is designed as a structurally closely related and biologically inactive analogue of NS11021. NS13558 did not elicit any significant opening of cloned human KCa1.1 channels, but maintained comparable biological activity towards other cardiac ion channels as compared to NS11021. In isolated perfused rat hearts subjected to ischemia-reperfusion, infarct size was reduced from 29% in control to 7% in NS11021 treated hearts. In comparison, the inactive derivate of NS11021, i.e., NS13558, did not confer any cardioprotection, demonstrated by an infarct size identical to control hearts. This suggests that NS11021 exerts its primary effect through KCa1.1 channels, which indicates an important role of these channels in protection against ischemia-reperfusion injuries. Furthermore, the study demonstrates a novel way of combining an activator of the KCa1.1 channel (NS11021) and its structurally closely related inactive analogue NS13558 to address the functional role of KCa1.1 channels, and we believe these novel tools may constitute a valuable addition to understanding the functional role of KCa1.1 channels under physiological and pathophysiological conditions.
Andreini,
Modification of the 1,2,3-triazole ring present in an effective in vitro inhibitor of the prostaglandin synthesis.
1989, Pubmed
Andreini,
Modification of the 1,2,3-triazole ring present in an effective in vitro inhibitor of the prostaglandin synthesis.
1989,
Pubmed
Bentzen,
Activation of big conductance Ca(2+)-activated K (+) channels (BK) protects the heart against ischemia-reperfusion injury.
2009,
Pubmed
,
Xenbase
Bentzen,
The small molecule NS11021 is a potent and specific activator of Ca2+-activated big-conductance K+ channels.
2007,
Pubmed
,
Xenbase
Cancherini,
Pharmacological and physiological stimuli do not promote Ca(2+)-sensitive K+ channel activity in isolated heart mitochondria.
2007,
Pubmed
Cao,
Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning.
2005,
Pubmed
Debska,
Large-conductance K+ channel openers NS1619 and NS004 as inhibitors of mitochondrial function in glioma cells.
2003,
Pubmed
Douglas,
The calcium-sensitive large-conductance potassium channel (BK/MAXI K) is present in the inner mitochondrial membrane of rat brain.
2006,
Pubmed
Edwards,
Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle.
1994,
Pubmed
Grunnet,
Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels.
2001,
Pubmed
,
Xenbase
Halestrap,
The role of mitochondria in protection of the heart by preconditioning.
2007,
Pubmed
Hansen,
Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643).
2006,
Pubmed
,
Xenbase
Heinen,
Mitochondrial Ca2+-induced K+ influx increases respiration and enhances ROS production while maintaining membrane potential.
2007,
Pubmed
Holland,
Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle.
1996,
Pubmed
Holland,
Heterocyclic tetrazoles, a new class of lipolysis inhibitors.
1967,
Pubmed
Jespersen,
Dual-function vector for protein expression in both mammalian cells and Xenopus laevis oocytes.
2002,
Pubmed
,
Xenbase
Longland,
The mycotoxin paxilline inhibits the cerebellar inositol 1,4, 5-trisphosphate receptor.
2000,
Pubmed
Nardi,
BK channel modulators: a comprehensive overview.
2008,
Pubmed
O'Rourke,
Mitochondrial ion channels.
2007,
Pubmed
Ohya,
Cardioprotective effects of estradiol include the activation of large-conductance Ca(2+)-activated K(+) channels in cardiac mitochondria.
2005,
Pubmed
Olesen,
Selective activation of Ca(2+)-dependent K+ channels by novel benzimidazolone.
1994,
Pubmed
Park,
The mitochondrial Ca2+-activated K+ channel activator, NS 1619 inhibits L-type Ca2+ channels in rat ventricular myocytes.
2007,
Pubmed
Sakamoto,
Molecular mechanisms for large conductance Ca2+-activated K+ channel activation by a novel opener, 12,14-dichlorodehydroabietic acid.
2006,
Pubmed
Sakamoto,
A novel opener of large-conductance Ca2+ -activated K+ (BK) channel reduces ischemic injury in rat cardiac myocytes by activating mitochondrial K(Ca) channel.
2008,
Pubmed
Saleh,
Stimulation of Ca2+-gated Cl- currents by the calcium-dependent K+ channel modulators NS1619 [1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one] and isopimaric acid.
2007,
Pubmed
Siemen,
Ca2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line.
1999,
Pubmed
Wang,
Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice.
2004,
Pubmed
Xu,
Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane.
2002,
Pubmed